FBIO

SEC source: 0001638599-17-000719 · doc4_4608.xml · derivative · entry 3

Harvey Jimmie · CIK 0001529687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,998

Underlying: Common Stock · 16,666 shares

Expires not disclosed

F3 · derivative.exercise_price: The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F2 · price: Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.

F3 · derivative.exercise_date: The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F3 · derivative.expiration_date: The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

SEC source: 0001638599-17-000719 · doc4_4608.xml · derivative · entry 2

Harvey Jimmie · CIK 0001529687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,998

Underlying: Common Stock · 16,666 shares

Expires not disclosed

F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F2 · price: Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.

F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2015, vesting one-third annually beginning on March 12, 2016. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

SEC source: 0001638599-17-000108 · doc4_4431.xml · nonDerivative · entry 1

LOBELL J JAY · CIK 0001172659 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 686,000

F1 · shares: One-third of the shares will vest on each of January 1, 2018, 2019 and 2020, and subject to continued service on the board of directors.

SEC source: 0001638599-17-000107 · doc4_4412.xml · derivative · entry 4

Klein Dov · CIK 0001647971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,999

Underlying: Common Stock · 26,666 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted 100,000 shares of restricted common stock of the Issuer on January 1, 2016 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on January 1, 2017. The Reporting Person deferred the receipt of 80% of the vested shares and, on January 1, 2017, received instead 26,666 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 26,666 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.

F2 · price: The Reporting Person was granted 100,000 shares of restricted common stock of the Issuer on January 1, 2016 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on January 1, 2017. The Reporting Person deferred the receipt of 80% of the vested shares and, on January 1, 2017, received instead 26,666 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 26,666 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.

F3 · derivative.exercise_date: Each deferred restricted stock unit will be settled in one share of the Issuer's common stock at the time and in the matter set forth in the Plan.

F3 · derivative.expiration_date: Each deferred restricted stock unit will be settled in one share of the Issuer's common stock at the time and in the matter set forth in the Plan.

SEC source: 0001638599-17-000107 · doc4_4412.xml · nonDerivative · entry 2

Klein Dov · CIK 0001647971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,001

F2 · price: The Reporting Person was granted 100,000 shares of restricted common stock of the Issuer on January 1, 2016 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on January 1, 2017. The Reporting Person deferred the receipt of 80% of the vested shares and, on January 1, 2017, received instead 26,666 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 26,666 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.

SEC source: 0001638599-17-000107 · doc4_4412.xml · nonDerivative · entry 1

Klein Dov · CIK 0001647971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,667

F1 · shares: One-third of the shares will vest on each of January 1, 2018, 2019 and 2020, and subject to continued service on the board of directors.

SEC source: 0001638599-17-000109 · doc4_4421.xml · nonDerivative · entry 1

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

F1 · shares: One-third of the shares will vest on each of January 1, 2018, 2019 and 2020, and subject to continued service on the board of directors.

SEC source: 0001638599-17-000106 · doc4_4430.xml · derivative · entry 2

Hoenlein Malcolm · CIK 0001294517 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,332

Underlying: Common Stock · 16,666 shares

Expires not disclosed

F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F2 · price: Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.

F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

SEC source: 0001638599-17-000105 · doc4_4411.xml · derivative · entry 3

Harvey Jimmie · CIK 0001529687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,332

Underlying: Common Stock · 16,666 shares

Expires not disclosed

F3 · derivative.exercise_price: The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F2 · price: Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.

F3 · derivative.exercise_date: The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F3 · derivative.expiration_date: The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

SEC source: 0001638599-17-000105 · doc4_4411.xml · derivative · entry 2

Harvey Jimmie · CIK 0001529687 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,332

Underlying: Common Stock · 16,666 shares

Expires not disclosed

F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F2 · price: Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.

F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

SEC source: 0001638599-17-000116 · doc4_4441.xml · nonDerivative · entry 2

ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,857,168

F2 · shares: Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan.

SEC source: 0001638599-17-000117 · doc4_4440.xml · nonDerivative · entry 1

WEISS MICHAEL S · CIK 0001038977 · Director · Exec. VC - Strategic Dev. · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,001,170

F1 · shares: Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan.

SEC source: 0001638599-17-000116 · doc4_4441.xml · nonDerivative · entry 1

ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,304,470

F1 · shares: These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan.

SEC source: 0001638599-16-001415 · doc4_4237.xml · nonDerivative · entry 2

Avgerinos George · CIK 0001578699 · SVP, Biologics Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,088

F2 · price: This transaction was executed in multiple trades ranging from $2.53 to $2.62. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001638599-16-001415 · doc4_4237.xml · nonDerivative · entry 1

Avgerinos George · CIK 0001578699 · SVP, Biologics Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,000

F1 · price: This transaction was executed in multiple trades ranging from $2.49 to $2.58. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001638599-16-001407 · doc4_4232.xml · nonDerivative · entry 1

Avgerinos George · CIK 0001578699 · SVP, Biologics Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,000

F1 · shares: Represents shares of common stock issued to the Reporting Person upon the partial vesting of an award of restricted stock units initially made on July 15, 2015.